Pfizer has released footage of a potential coronavirus vaccine, as the drug giant aims to produce 100 million doses by the end of the year.
The Manhattan-based company told Mail on Sunday that it was preparing to use Emergency in the U.S. by November, as it had prepared “several hundred doses” of the drug.
Ben Osobon, the firm’s UK boss, also told the paper that scientists at its leading British lab had also found drugs that could potentially cure Covid-19, as opposed to just one preventive vaccine.
Osobon said the company was building a huge stockpile of its current vaccine candidate in Belgium “at risk and on scale” and called it “tremendously exciting”.
“The hope here is that we inevitably come up with a drug that disrupts the virus and ultimately prevents it from worsening the patient’s condition,” he told the Mail’s financial site.
“It was great to see the first bottle coming out of the product line. It brought a tremendous smile to my face to see how all this work really results in production, ”he said.
But, “we can move forward as fast as science allows us,” he stressed.
Pfizer expects the vaccine to work by the end of this month, but the company said the shot is still safe and could be properly manufactured to authorize so-called emergency use, CEO Albert Borla said Friday.
If safe, he expects his company to hit the U.S. in the third week of November. Will take advantage of the crisis.
“We are working at the speed of science,” he said.